Walleye Capital LLC Bridge Bio Pharma, Inc. Call Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $184,107 - $241,010	-7,700 Reduced 27.11%	20,700 $527,000
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $503,700 - $679,776	21,900 Added 336.92%	28,400 $719,000
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $177,775 - $262,925	6,500 New	6,500 $200,000
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $141,876 - $294,084	8,400 Added 336.0%	10,900 $287,000
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $45,186 - $61,234	-3,400 Reduced 57.63%	2,500 $43,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $42,303 - $109,445	5,900 New	5,900 $97,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.52B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.